CIPLA LTD FDA Approval ANDA 216048

ANDA 216048

CIPLA LTD

FDA Drug Application

Application #216048

Application Sponsors

ANDA 216048CIPLA LTD

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2022-11-01STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

CIPLA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216048
            [companyName] => CIPLA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"MIDAZOLAM","activeIngredients":"MIDAZOLAM","strength":"5MG","dosageForm":"SPRAY;NASAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/01\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-11-01
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.